US Edition
News from usawire.com
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top usawire.com News
Eli Lilly(Reuters) -Eli Lilly’s experimental obesity drug, eloralintide, helped some patients lose 11.5% of their body weight at 12 weeks in an early-stage study, an investor note by brokerage Cantor Fitzgerald showed on Friday. The 12-week result was published in an abstract ahead of the American Diabetes Association conference in Chicago, the brokerage said. Cantor analyst Prakhar Agrawal said the data on eloralintide looked strong in terms of weight l…See the Story
Eli Lilly’s experimental obesity drug shows over 11% weight loss in early trial
Coverage: 2 sources
Bermuda · BermudaThe Bermuda Hospitals Board has temporarily halted MRI services because of technical challenges.
Terricca Smith, diagnostic imaging manager, said that a problem had arisen with connections between the...See the Story
MRI Services Paused over Technical Problems
100% Center coverage: 1 sources
How Voice AI Can Slash Healthcare Clinicians' Workloads — and Offer Companionship for Older Adults
100% Left coverage: 1 sources
